| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. | Gastroenterology | 2006 | 2.32 |
| 2 | Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine. | PLoS One | 2011 | 1.21 |
| 3 | Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy. | Hum Mol Genet | 2012 | 1.11 |
| 4 | Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate. | Liver Int | 2012 | 0.86 |
| 5 | Influence of prothymosin-alpha on HIV-1 target cells. | Ann N Y Acad Sci | 2007 | 0.84 |
| 6 | Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. | Int J Cancer | 2004 | 0.80 |
| 7 | The ABRF MARG microarray survey 2005: taking the pulse of the microarray field. | J Biomol Tech | 2006 | 0.77 |